Browse the full directors' dealings record of 넥스트바이오메디컬, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Market capitalisation: €726.5bn. The latest transaction was reported on 7 May 2026 (Purchase). Among the most active insiders: 한명식. Every trade is openly available.